Stocks · News reference
UBS Maintains Buy on Albemarle, Lowers Price Target to $150
UBS analyst Joshua Spector maintains Albemarle (NYSE:ALB) with a Buy and lowers the price target from $175 to $150.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Microporous Materials Market - Global Strategic Business Report: Secure your share of a $1.3B revenue expansion to $7.2B by 2030. BASF, Honeywell UOP, Albemarle and Evonik Accelerating the MOF andCarbon-Capture Race
The global microporous materials market is projected to grow from $5.9 billion in 2024 to $7.2 billion by 2030, expanding at a 3.2% CAGR. Growth is driven by rising demand for carbon capture, clean fuels, purification, and advanced manufacturing applications. Key players including BASF, Honeywell UOP, Albemarle, and Evonik are accelerating development of metal-organic frameworks (MOFs) and carbon-capture technologies. Asia-Pacific, particularly China, is expected to see strong growth at 5.8% CAGR.
Trump, Greenland Deal Puts Rare-Earth ETFs In Focus: Funds to Watch as US Targets China’s Supply Chain
Stocks related to Greenland surged after the new U.S.-Greenland deal. Here’s what it could mean for rare-earth and critical-minerals ETFs.